Found 4370 articles for: ""
Safety of Occluded 4% Liposomal Lidocaine Cream
July 2006 | Volume 5 | Issue 7 | Original Article | 618 | Copyright © July 2006
The use of topical anesthesia for pain control for dermatologic procedures is widespread. In addition to clinical procedures, such as skin biopsies, lesion removal, and electrocautery, topical anesth...
Read MoreClinical Evaluation of Fluid Extract of Chamomilla recutita for Oral Painful Ulcers, Especially Aphthae
July 2006 | Volume 5 | Issue 7 | Original Article | 612 | Copyright © July 2006
Recurrent aphthous stomatitis is a difficult to treat and quite common chronic inflammatory disease of the oral mucosa. This study evaluates the fluid extract from Chamomilla recutita’s safety and ...
Read MoreAnti-Inflammatory Properties of Narrow-Band Blue Light
July 2006 | Volume 5 | Issue 7 | Original Article | 605 | Copyright © July 2006
Background: Narrow-band blue light (420 nm) has demonstrated safety and efficacy in the treatment of acne vulgaris. It works by exhibiting a phototoxic effect on the heme metabolism of Propionibacter...
Read MoreBotulinum Toxin Type A in the Treatment of Dermatochalasis: An Open-Label, Randomized, Dose-Comparison Study
July 2006 | Volume 5 | Issue 7 | Original Article | 596 | Copyright © July 2006
Objective: To compare the efficacy and safety of 2 doses of botulinum toxin type A in the treatment of dermatochalasis. Methods: Forty patients with mild to moderate dermatochalasis were randomly ass...
Read MoreCryotherapy in the Treatment of Keloids
July 2006 | Volume 5 | Issue 7 | Original Article | 591 | Copyright © July 2006
Background: Despite their benign nature, keloids may constitute a severe aesthetic and, in some cases, functional problem with important repercussions on patients’ quality of life. There is no cons...
Read MoreClinical Trial Review
June 2006 | Volume 5 | Issue 6 | Features | 573 | Copyright © June 2006
Schools of Pharmacology
June 2006 | Volume 5 | Issue 6 | Features | 571 | Copyright © June 2006
Pipeline Previews
June 2006 | Volume 5 | Issue 6 | Features | 569 | Copyright © June 2006
Washington Whispers
June 2006 | Volume 5 | Issue 6 | Features | 565 | Copyright © June 2006
Furosemide-Induced Bullous Pemphigoid: Case Report and Review of Literature
June 2006 | Volume 5 | Issue 6 | Case Reports | 562 | Copyright © June 2006
Bullous pemphigoid (BP) is an acquired autoimmune disease characterized by subepidermal vesicles and bullae. The etiology for BP is mostly idiopathic with the highest occurrence in elderly patients; ...
Read MoreHenry Ford Hospital Dermatology Experience with Levulan Kerastick and Blue Light Photodynamic Therapy
June 2006 | Volume 5 | Issue 8 | Case Reports | 556 | Copyright © June 2006
Background and Objectives: Photodynamic therapy (PDT) with topical 5-aminolevulinic acid (ALA) is becoming a more popular dermatologic procedure. Newer protocols have virtually eliminated any associa...
Read MoreThe Use of 308-nm Excimer Laser For Dermatoses: Experience with 34 Patients
June 2006 | Volume 5 | Issue 6 | Case Reports | 550 | Copyright © June 2006
Targeted phototherapy has been utilized in the past few years for the treatment of various dermatoses. In this article, we summarize the experience of using 308-nm excimer laser at Henry Ford Hospita...
Read MoreLife-Threatening Pustular and Erythrodermic Psoriasis Responding to Infliximab
June 2006 | Volume 5 | Issue 6 | Case Reports | 546 | Copyright © June 2006
Pustular and erythrodermic psoriasis can be a debilitating and recalcitrant disease which may result in secondary complications such as sepsis, electrolyte imbalance, renal failure, and heart failure...
Read MoreExcess Salt and Pepper Hair Treated with a Combination of Laser Hair Removal and Topical Eflornithine HCl
June 2006 | Volume 5 | Issue 6 | Case Reports | 544 | Copyright © June 2006
A common problem among aging women, salt and pepper facial hair poses a significant psychosocial impact as well as a challenge for treatment. Various laser therapies or topical eflornithine HCl 13.9%...
Read MoreEtanercept for Chronic Progressive Cutaneous Sarcoidosis
June 2006 | Volume 5 | Issue 6 | Case Reports | 538 | Copyright © June 2006
Sarcoidosis is a chronic, multisystem, granulomatous disease that has various cutaneous manifestations. Chronic cutaneous sarcoidosis can be difficult to manage. Patients often need systemic corticos...
Read MorePlasmapheresis for Refractory Urticarial Vasculitis in a Patient with B-Cell Chronic Lymphocytic Leukemia
June 2006 | Volume 5 | Issue 6 | Case Reports | 534 | Copyright © June 2006
Background: Urticarial vasculitis is a form of cutaneous leukocytoclastic vasculitis clinically characterized by persistent and often painful urticarial lesions. Numerous systemic diseases have been a...
Read MoreClobetasol Propionate for Psoriasis: Are Ointments Really More Potent?
June 2006 | Volume 5 | Issue 6 | Case Reports | 527 | Copyright © June 2006
Background: Clobetasol propionate is the most common topical therapy used for psoriasis in the US. Conventional dermatologic wisdom is that ointment preparations provide the highest potency (due to t...
Read MoreCytokines in Dermatology
June 2006 | Volume 5 | Issue 6 | Original Article | 520 | Copyright © June 2006
Cytokines are polypeptides that are produced by various cell types and act in an autocrine or paracrine manner. They have many different biological actions and have been used in dermatology to treat ...
Read MoreImmune Protection, Natural Products, and Skin Cancer: Is There Anything New Under the Sun?
June 2006 | Volume 5 | Issue 6 | Original Article | 512 | Copyright © June 2006
Non-melanoma skin cancers such as squamous cell carcinoma and basal cell carcinoma are the most common types of human neoplasms, representing one third of all new malignancies diagnosed in the US. Th...
Read MoreTacrolimus Ointment 0.1% Alone and in Combination with Medium-Dose UVA1 in the Treatment of Palmar or Plantar Psoriasis
June 2006 | Volume 5 | Issue 6 | Original Article | 505 | Copyright © June 2006
Psoriasis is a common skin condition affecting approximately 2.6% of the population in the US. The most effective current therapies for psoriasis have suppressive activity against T lymphocytes direc...
Read More